Fatigue management — whether through a symptom-specific self-management program or through general education regarding managing multiple sclerosis (MS) — may help people with MS in keeping fatigue levels stable in the long term, a recent study suggests. Indeed, the benefits of such programs were found to remain in effect…
Therapy and counseling
ImStem Biotechnology announced that the first patient in its Phase 1 clinical trial for IMS001, an investigational treatment for multiple sclerosis (MS), has been dosed at the Shepherd Center in Atlanta. The trial (NCT04956744) is recruiting participants with an MS diagnosis ages 18 to 65. More information…
In this installment of our “Expert Voices” series, Multiple Sclerosis News Today asked psychologist Gayle Lewis, PhD, to answer some of your questions related to sex and intimacy for people with multiple sclerosis (MS) and their partners. Gayle Lewis is a psychologist and psychoanalyst currently in private practice in New…
A single dose of NVG-291, a potential nerve repair therapy for multiple sclerosis (MS), was safe and well-tolerated among healthy volunteers in a Phase 1 safety trial, and was found to have favorable pharmacological properties, new data show. Given the positive results thus far, a safety committee supervising…
Mindfulness-based interventions (MBIs) helped people with multiple sclerosis (MS) cope with symptoms, and many said they would recommend these practices to others living with MS, according to a review of published studies related to patients’ experiences. The participants reported the benefits of a shared experience, but stressed the importance…
A new podcast series hosted and produced by cultural expert Jess Weiner aims to help girls, non-binary individuals, and women, with their confidence. The target audience includes those with physical disorders, such as multiple sclerosis (MS), that may affect their self-image. Called “Dominant Stories with Jess Weiner,” the 12-episode…
Whether we are aware of it or not, music infiltrates every part of our daily lives. It may be as subtle and inadvertent as music playing in the background at the grocery store or as obvious and intentional as jamming to tunes on our own playlists. But music also can…
Cognitive rehabilitation is an effective therapy for cognitive problems brought on by multiple sclerosis (MS), a review study highlights. “Clinicians should consider this low-cost, low-risk, yet effective treatment approach for their patients,” its researchers wrote. The study, “Neurological update: cognitive rehabilitation in multiple sclerosis,” was published…
The Multiple Sclerosis Association of America (MSAA) is inviting people to participate in its Improving Lives Through Art Series, a cycle of virtual fundraising events starting Sept. 14. The kick-off event of this four-part fall series is a virtual follow-along painting experience. Tickets can be purchased here…
Cytocom has joined forces with La Jolla Institute for Immunology (LJI) to discover and develop new immune-modulating therapies targeting toll-like receptors (TLRs) for autoimmune diseases such as multiple sclerosis (MS), cancer, and infectious and chronic inflammatory conditions. TLRs are an important family of protein receptors found at the surface…
Personal Zen, a digital anxiety management tool developed by Wise Therapeutics, eased anxiety and broad negative moods in people with pediatric-onset multiple sclerosis (MS), according to the results of a pilot study. This app-based therapy, a “mobile gamified version” of what is known as attention bias modification…
I’ve written about trigeminal neuralgia (TN), which entails severe facial pain, many times. Let me count the ways. Please excuse me while I go off and search through my columns. I’ll be a while. Well, it turns out I’ve written specifically about it only three times,…
I have a weird secret. I’m sure it’s not the norm for someone with a chronic illness to enjoy this as much as I do, but it always occupies my free time: I love medical dramas. They leave me enthralled with their technical and medical jargon, and their portrayal of…
“Look on the bright side.” Someone just said this to me days ago regarding the loss of a very dear friend. The bright side? I demanded to know what the bright side of this situation could be. There was no satiable explanation given in that moment. I am also…
Using high-efficacy therapies as a first treatment for multiple sclerosis (MS) patients significantly increases the likelihood of having no evidence of disease activity after one and two years, compared to using moderately effective therapies, according to a real-world study of Norwegian patients. However, with each additional attempted treatment, the…
Vesicles containing the chemotherapeutic agent doxorubicin can be used to destroy the aberrant, myelin-damaging immune cells that contribute to multiple sclerosis (MS), suppressing the progression of the neurodegenerative disorder, according to recent research findings using a mouse model. If further validated, this technique could provide physicians with a new…
Abata Therapeutics has opened with $95 million in financing, and plans to use regulatory T-cells to treat autoimmune and inflammatory diseases, starting with progressive forms of multiple sclerosis (MS). Money raised will be used to support work for three clinical trials it plans to initiate in 2025, including…
A $1 million gift from Velocity Global will help expand First Descents, an adventure program for young adults living with multiple sclerosis (MS) or other serious chronic conditions. The money will go toward program development and is expected to help First Descents reach 1,000 MS patients over…
BurnAlong and the Shepherd Center, a leading rehabilitation hospital in the U.S., have established a partnership to bring tailored rehabilitation classes to people with multiple sclerosis (MS) and other neuromuscular diseases worldwide. The video classes, designed by clinicians, therapists, and wellness professionals at the Shepherd Center, based in Atlanta,…
Screaming. The pain from this trigeminal neuralgia (TN) attack was worse than any previous attack. And there have been aplenty. I couldn’t function! But boy could I scream. It was 8 a.m. and I was stirring awake. My tongue merely touched one of the bottom molars on the…
NICE Again Says No to Adding Zeposia to Health System for England and Wales Reading this news, I’m again reminded of the major difference between the healthcare system in the U.S. and those in most of the rest of the world. While the systems outside the U.S. provide most…
When I started hypnotherapy about five weeks ago, my therapist asked me questions about where I felt I was in my journey. He asked me to rate my anxiety on a scale of 1-10, and I said 9. Candidly, it was…
MindMaze’s animated ‘games,’ designed to aid in recovering motor and cognitive skills in people with neurological disabilities, such as multiple sclerosis (MS), will now be more widely available to patients worldwide. The brain technology company announced four new partnerships that will enable patients in Latin America, the Middle East,…
After speaking about hypnotherapy recently with a few people I know, I realized that many of them didn’t know that hypnosis can be used to manage stress and anxiety. One person remarked, “What do I need to say to get you to quack like a duck?” Well, it’s not like…
I recently wrote about my decision to try hypnotherapy. I’d been feeling out of control over my mental state following a multiple sclerosis flare. I finally admitted that I needed help. I had an initial phone consultation with my…
Recently, I’ve been struggling through an MS flare. I have been numb, mostly from my neck down, which is reminiscent of my first relapse eight years ago. Numb and slightly weak hands make it extremely difficult to draw.
“Take a breath and give one away.” — Marisa Peer Recently, I started doing guided meditation by Marisa Peer, a rapid transformational therapy trainer and best-selling author. Her meditations are freely available on Spotify and cover a range of topics to…
Wise Therapeutics intends to seek U.S. Food and Drug Administration (FDA) approval of an anxiety management therapy for multiple sclerosis (MS), following the positive results of a clinical trial. In addition to conducting a proof-of-concept study in MS, Wise tested its digital technique — called attention bias…
The European Commission has approved Novartis’ Kesimpta (ofatumumab) as the first self-administered, at-home B-cell-targeting therapy for adults with relapsing forms of multiple sclerosis (MS) and active disease. Active disease in these forms, which include clinically isolated syndrome, relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS),…
Photo courtesy of Joanna Hammond Day 29 of 31 This is Joanna Hammond’s story: I was diagnosed with MS back in January 2018, and I felt like my world had fallen apart. One of the very best things I did very quickly was to attend my local…